These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 1493908

  • 41. Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis of 141 cases.
    Raspadori D, Lauria F, Ventura MA, Rondelli D, Visani G, de Vivo A, Tura S.
    Leuk Res; 1997 Jul; 21(7):603-7. PubMed ID: 9301680
    [Abstract] [Full Text] [Related]

  • 42. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O, Mesárosová A, Koníková M, Kusenda J, Glasová M, Klobusická M.
    Neoplasma; 1993 Jul; 40(5):275-81. PubMed ID: 8272155
    [Abstract] [Full Text] [Related]

  • 43. [Immunophenotypes, cytogenetics and clinical features of 192 patients with acute myeloid leukemia].
    Tong HX, Wang HH, Zhang JH, Liu ZG, Zheng YC, Wang YX.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1174-8. PubMed ID: 19840445
    [Abstract] [Full Text] [Related]

  • 44. CD34 expression fails to predict the outcome in adult acute myeloid leukemia.
    Ciolli S, Leoni F, Caporale R, Pascarella A, Salti F, Rossi-Ferrini P.
    Haematologica; 1993 Oct; 78(3):151-5. PubMed ID: 7690733
    [Abstract] [Full Text] [Related]

  • 45. Classification of acute myeloid leukemias--a comparison of FAB and immunophenotyping.
    Drexler HG.
    Leukemia; 1987 Oct; 1(10):697-705. PubMed ID: 3312833
    [Abstract] [Full Text] [Related]

  • 46. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
    Lewis RE, Cruse JM, Webb RN, Sanders CM, Beason K.
    Exp Mol Pathol; 2007 Oct; 83(2):269-73. PubMed ID: 17603036
    [Abstract] [Full Text] [Related]

  • 47. CD34+/CD33+ blast cells: correlation with FAB subtypes.
    Rigolin GM, Lanza F, Ferrari L, Castoldi G.
    Leuk Lymphoma; 1995 Oct; 18 Suppl 1():43-8. PubMed ID: 7496354
    [Abstract] [Full Text] [Related]

  • 48. Prognostic significance of CD56 antigen expression in acute myeloid leukemia.
    Di Bona E, Sartori R, Zambello R, Guercini N, Madeo D, Rodeghiero F.
    Haematologica; 2002 Mar; 87(3):250-6. PubMed ID: 11869936
    [Abstract] [Full Text] [Related]

  • 49. CD33, CD96 and Death Associated Protein Kinase (DAPK) Expression Are Associated with the Survival Rate and/or Response to the Chemotherapy in the Patients with Acute Myeloid Leukemia (AML).
    Jiang Y, Xu P, Yao D, Chen X, Dai H.
    Med Sci Monit; 2017 Apr 09; 23():1725-1732. PubMed ID: 28391288
    [Abstract] [Full Text] [Related]

  • 50. [Immunophenotypic Analysis of Patients with CD56⁺ Acute Myeloid Leukemia].
    Guo R, Shen AL, Wang Y, Liu L, Zhang JF, Wang R, Li JY, Wu YJ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct 09; 23(5):1231-4. PubMed ID: 26524014
    [Abstract] [Full Text] [Related]

  • 51. Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia.
    Schwarzinger I, Valent P, Köller U, Marosi C, Schneider B, Haas O, Knapp W, Lechner K, Bettelheim P.
    J Clin Oncol; 1990 Mar 09; 8(3):423-30. PubMed ID: 2307987
    [Abstract] [Full Text] [Related]

  • 52. Expression of CD24 (BA-1) predicts monocytic lineage in acute myeloid leukemia.
    Raife TJ, Lager DJ, Kemp JD, Dick FR.
    Am J Clin Pathol; 1994 Mar 09; 101(3):296-9. PubMed ID: 7510927
    [Abstract] [Full Text] [Related]

  • 53. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.
    Liu YR, Zhu HH, Ruan GR, Qin YZ, Shi HX, Lai YY, Chang Y, Wang YZ, Lu D, Hao L, Li JL, Li LD, Jiang B, Huang XJ.
    Leuk Res; 2013 Jul 09; 37(7):737-41. PubMed ID: 23601747
    [Abstract] [Full Text] [Related]

  • 54. Morphologic immunophenotypic and cytogenetic patterns of adult acute myeloid leukemia in Saudi Arabia.
    Roberts GT, Spence DG, Padmos MA, Sheth KV, Clink H, Ernst P.
    Leuk Res; 1992 Jul 09; 16(2):181-90. PubMed ID: 1545571
    [Abstract] [Full Text] [Related]

  • 55. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
    Xu B, Hu C, Miao XD, Wu YH, Yi ZS, Yang Y, Meng FY, Feng R, Liu QF, Liu XL, Zheng WY.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct 09; 23(10):1043-6. PubMed ID: 14559689
    [Abstract] [Full Text] [Related]

  • 56. Identification of acute myeloid leukemia in dogs using flow cytometry with myeloperoxidase, MAC387, and a canine neutrophil-specific antibody.
    Villiers E, Baines S, Law AM, Mallows V.
    Vet Clin Pathol; 2006 Mar 09; 35(1):55-71. PubMed ID: 16511792
    [Abstract] [Full Text] [Related]

  • 57. Differential expression of the carcinoembryonic antigen-related cell adhesion molecules panCD66, CD66a, CD66c and of sialyl-Lewis x (CD15s) on blast cells of acute leukemias.
    Ratei R, Karawajew L, Schabath R, Ehrfeldt A, Grunert F, Ludwig WD.
    Int J Hematol; 2008 Mar 09; 87(2):137-143. PubMed ID: 18299959
    [Abstract] [Full Text] [Related]

  • 58. Expression of immunological markers on leukemic cells before and after cryopreservation and thawing.
    Campos L, Guyotat D, Larese A, Archimbaud E, Mazet L, Ehrsam A, Fiere D.
    Cryobiology; 1988 Feb 09; 25(1):18-22. PubMed ID: 3162412
    [Abstract] [Full Text] [Related]

  • 59. Prognostic value of lymphocyte surface markers in acute myeloid leukemia.
    Ball ED, Davis RB, Griffin JD, Mayer RJ, Davey FR, Arthur DC, Wurster-Hill D, Noll W, Elghetany MT, Allen SL.
    Blood; 1991 May 15; 77(10):2242-50. PubMed ID: 1709379
    [Abstract] [Full Text] [Related]

  • 60. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
    Urbano-Ispizua A, Matutes E, Villamor N, Sierra J, Pujades A, Reverter JC, Feliu E, Cervantes F, Vives-Corrons JL, Montserrat E.
    Br J Haematol; 1992 Jun 15; 81(2):178-83. PubMed ID: 1322689
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.